Literature DB >> 18176901

[Handling of the gastroesophageal reflux disease (GERD) during pregnancy--a review].

S Fill1, M Malfertheiner, S-D Costa, K Mönkemüller.   

Abstract

Gastroesophageal reflux disease (GERD) is common during pregnancy. The pathogenesis is a decrease in lower oesophageal sphincter pressure caused by female sex hormones, especially progesterone. The most common symptom of GERD is heartburn. Nevertheless, serious reflux complications during pregnancy are rare. In contrast to non-pregnant patients, GERD during pregnancy should be managed with a step-up algorithm beginning with lifestyle modifications and dietary changes. Antacids or sucralfate are considered the first-line on-demand drug therapy. If symptoms persist, any of the histamine-2-receptor antagonists can be used. Proton pump inhibitors are reserved for women with intractable symptoms or complicated reflux disease. Usually, heartburn during pregnancy resolves soon after delivery but little is known about the late sequelae or, respectively, an influence on subsequent pregnancies. Accordingly a prospective study (longitudinal cohort analysis) is currently underway.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 18176901     DOI: 10.1055/s-2007-981336

Source DB:  PubMed          Journal:  Z Geburtshilfe Neonatol        ISSN: 0948-2393            Impact factor:   0.685


  2 in total

1.  Inhibition of the BMP pathway prevents development of Barrett's-associated adenocarcinoma in a surgical rat model.

Authors:  Wytske M Westra; Danielle Straub; Francesca Milano; Navtej S Buttar; Kenneth K Wang; Kausilia K Krishnadath
Journal:  Dis Esophagus       Date:  2022-05-10       Impact factor: 2.822

2.  A prospective longitudinal cohort study: evolution of GERD symptoms during the course of pregnancy.

Authors:  Sara Fill Malfertheiner; Maximilian V Malfertheiner; Siegfried Kropf; Serban-Dan Costa; Peter Malfertheiner
Journal:  BMC Gastroenterol       Date:  2012-09-24       Impact factor: 3.067

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.